Cargando…
Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients
Linezolid combined with rifampicin has shown excellent clinical outcomes against infection by multi-resistant Gram-positive bacteria. However, several studies have indicated that rifampicin reduces the plasma concentration of linezolid in patients with severe infection. Linezolid has been recommende...
Autores principales: | Yan, Pan, Shi, Qun-Zhi, Hu, Yi-Xing, Zeng, Ying, Lu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662288/ https://www.ncbi.nlm.nih.gov/pubmed/38026932 http://dx.doi.org/10.3389/fphar.2023.1260535 |
Ejemplares similares
-
Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients
por: Wu, Fan, et al.
Publicado: (2022) -
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023) -
Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
por: Yuan, Yuan, et al.
Publicado: (2022) -
Effects of a rifampicin pre-treatment on linezolid pharmacokinetics
por: Okazaki, Fumiyasu, et al.
Publicado: (2019) -
The Inhibition Effect of Linezolid With Reyanning Mixture on MRSA and its Biofilm is More Significant than That of Linezolid Alone
por: Zhang, Lulu, et al.
Publicado: (2022)